Harbour Capital Advisors’s BioNTech BNTX Stock Holding History

Harbour Capital Advisors’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-6,043	Closed	-$753K	–	256
2023 Q1	$753K	Hold	6,043	–	–	0.23%	102
2022 Q4	$898K	Sell	6,043 -242	-4%	-$37.2K	0.3%	84
2022 Q3	$850K	Hold	6,285	–	–	0.29%	88
2022 Q2	$937K	Hold	6,285	–	–	0.31%	82
2022 Q1	$1.07M	Hold	6,285	–	–	0.29%	86
2021 Q4	$1.62M	Sell	6,285 -45	-0.7%	-$12.3K	0.4%	71
2021 Q3	$1.73M	Buy	6,330 +180	+3%	+$57.2K	0.45%	60
2021 Q2	$1.38M	Hold	6,150	–	–	0.37%	79
2021 Q1	$672K	Buy	+6,150	New	+$653K	0.2%	122
2020 Q4	–	Sell	-6,150	Closed	-$426K	–	88
2020 Q3	$426K	Hold	6,150	–	–	0.16%	139
2020 Q2	$410K	Buy	+6,150	New	+$307K	0.17%	130

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Harbour Capital Advisors's BNTX Position: Q2 2023 in Review

Harbour Capital Advisors sold out of BioNTech (BNTX) in Q2 2023, closing a stake of 6,043 shares — an estimated $753K sold.

Harbour Capital Advisors first reported a position in BNTX in Q2 2020 and held it in 11 quarters. The position peaked at $1.73M in Q3 2021. 253 funds tracked by Wall St. Rank hold BNTX as of Q2 2023.

Harbour Capital Advisors reported no remaining BioNTech position as of Q2 2023 after selling out during the quarter.
Harbour Capital Advisors sold 6,043 BioNTech shares in Q2 2023, an estimated $753K.
Harbour Capital Advisors first reported a position in BioNTech in Q2 2020 and held it in 11 quarters.
Harbour Capital Advisors's BioNTech position peaked at $1.73M in Q3 2021.
253 funds tracked by Wall St. Rank held BioNTech as of Q2 2023.

Based on Harbour Capital Advisors's 13F filing for Q2 2023, filed 10 Jul 2023.